Abbott India Ltd Valuation Shifts Shape Weekly Trend

Technical Momentum: The week was characterised by a shift towards bearish technical indicators, including a negative MACD and trading below key moving averages. While short-term momentum showed some resilience, the overall trend suggests consolidation or correction rather than a clear recovery. Valuation Dynamics: Abbott India’s valuation profile moderated slightly from 'very expensive' to 'expensive', with a P/E ratio of 34.08 and elevated enterprise value multiples. Despite this, the stock remains priced at a premium relative to many pharmaceutical peers, reflecting ongoing market caution. Relative Performance: The stock’s weekly decline of 0.85% was less severe than the Sensex’s 1.11% fall, indicating relative outperformance amid broader market weakness. However, the price remains below the week’s opening level, underscoring persistent challenges. Profitability Metrics: Robust return on capital employed (67.48%) and return on equity (33.82%) highlight operational efficiency, providing a foundation amid valuation and technical pressures.